Study to Assess Safety and PET Imaging Characteristics of a Novel Senescence-specific Radiotracer [18F]FPyGal (2-[Fluorine-18]Fluoro-3-pyridinyl-β-D-galactopyranoside)

NCT04536454 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
32
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital Tuebingen